Sponsor:
Ottawa Hospital Research Institute
Code:
NCT05487274
Conditions
Osteoarthritis Shoulder
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Interventions
Total Shoulder Arthroplasty + augmented glenoid component
Reverse Shoulder Arthroplasty
Brief summary:
Conditions
Osteoarthritis Shoulder
Study ID
NCT05487274
Start date
Aug 9, 2022
Status verified date
Apr, 2024
Completion date
Dec 31, 2029
Anticipated
Primary completion date
Mar 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Enrollment
108 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Total Shoulder Arthroplasty (anatomic) + augmented glenoid component
active comparator: Reverse Shoulder Arthroplasty
Interventions
Total Shoulder Arthroplasty + augmented glenoid component
Reverse Shoulder Arthroplasty
Primary outcome measure
Central contacts
Locations
Ottawa Hospital Research Institute
Recruiting
Ottawa, Ontario, Canada, K1H8L6
Contacts
Principal Investigator:
Peter Lapner, MD FRCSC
Sponsor
Ottawa Hospital Research Institute
Last update posted
Apr 30, 2024
Last verified
Apr, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ottawa Hospital Research Institute on 2024-04-30.